Superinfection of a chimpanzee with a second strain of human immunodeficiency virus
- PMID: 2446009
- PMCID: PMC256026
- DOI: 10.1128/JVI.61.12.4026-4029.1987
Superinfection of a chimpanzee with a second strain of human immunodeficiency virus
Abstract
Two chimpanzees, one (C-499) infected with the acquired immunodeficiency syndrome-associated retrovirus type 2 (ARV-2) strain of human immunodeficiency virus (HIV) and one (C-560) infected with the lymphadenopathy-associated virus type 1 (LAV-1) strain of HIV, were inoculated with approximately 10(4) tissue culture infective doses of the reciprocal strain. At the time of the second inoculation, both chimpanzees had high titers of HIV-specific antibodies, including antibodies that neutralized both virus strains. After inoculation of the second strain of HIV, the antibody titers in both chimpanzees increased 4- to 10-fold, and in one chimpanzee (C-499), the numbers of infectious peripheral blood mononuclear cells (PBMC) increased 1,000-fold to levels that are comparable with those observed after primary HIV infections. By restriction enzyme analysis of virus recovered from PBMC, both ARV-2 and LAV-1 were identified in C-499, thus demonstrating that superinfection had occurred.
Similar articles
-
Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome.J Virol. 1986 Apr;58(1):116-24. doi: 10.1128/JVI.58.1.116-124.1986. J Virol. 1986. PMID: 3005641 Free PMC article.
-
Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses.J Virol. 1987 Oct;61(10):3173-80. doi: 10.1128/JVI.61.10.3173-3180.1987. J Virol. 1987. PMID: 2442411 Free PMC article.
-
Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.Proc Natl Acad Sci U S A. 1988 Jun;85(12):4478-82. doi: 10.1073/pnas.85.12.4478. Proc Natl Acad Sci U S A. 1988. PMID: 2454471 Free PMC article.
-
Specificity of chimpanzee antibodies binding a strain-specific HIV-1 neutralization epitope of the external envelope.J Med Primatol. 1989;18(3-4):357-62. J Med Primatol. 1989. PMID: 2474656
-
Nonclassical mucosal antibodies predominate in genital secretions of HIV-1 infected chimpanzees.J Med Primatol. 1995 Feb;24(2):53-60. doi: 10.1111/j.1600-0684.1995.tb00146.x. J Med Primatol. 1995. PMID: 8613973
Cited by
-
Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus.J Virol. 1997 Nov;71(11):8141-8. doi: 10.1128/JVI.71.11.8141-8148.1997. J Virol. 1997. PMID: 9343164 Free PMC article.
-
Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure.J Virol. 2004 Jan;78(1):94-103. doi: 10.1128/jvi.78.1.94-103.2004. J Virol. 2004. PMID: 14671091 Free PMC article.
-
Mice chronically infected with chimeric HIV resist peripheral and brain superinfection: a model of protective immunity to HIV.J Neuroimmune Pharmacol. 2012 Jun;7(2):380-7. doi: 10.1007/s11481-011-9316-1. Epub 2011 Oct 11. J Neuroimmune Pharmacol. 2012. PMID: 21987348 Free PMC article.
-
The development of an AIDS vaccine: progress and promise.Public Health Rep. 1988 May-Jun;103(3):230-6. Public Health Rep. 1988. PMID: 3131812 Free PMC article. Clinical Trial.
-
Quasispecies and naturally occurring superinfection in feline immunodeficiency virus infection.Arch Virol. 1996;141(9):1703-13. doi: 10.1007/BF01718293. Arch Virol. 1996. PMID: 8893792
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical